Rubicon Research IPO GMP Today ₹128 Get the Latest Updates on Rubicon Research ipo Grey market premium (GMP), Kostak rate, and Subject to Sauda Price along with Expected Listing Gains. Track daily GMP trends and IPO details before investing.
Latest Rubicon Research IPO GMP (Grey Market Premium)
Rubicon Research IPO GMP Today is – ₹128 Per Share
Kostak Rate – Not Available
Subject to Sauda – ₹3,200
Expected Listing Gain – 26.39%
Rubicon Research IPO GMP Price to Down a high to low of ₹62 Rupay on Oct 04 and a High Price of ₹128 on Oct 14, 2025 Showing Strong Market demand.
Rubicon Research IPO GMP Live – Day-wise Trend ( Table)
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Profit |
|---|---|---|---|---|
| 14-10-2025 | 485.00 | ₹128 | ₹613 (26.39%) | ₹3,840 |
| 13-10-2025 | 485.00 | ₹97 | ₹582 (20.00%) | ₹2,910 |
| 12-10-2025 | 485.00 | ₹81 | ₹566 (16.70%) | ₹2,430 |
| 11-10-2025 | 485.00 | ₹81 | ₹566 (16.70%) | ₹2,430 |
| 10-10-2025 | 485.00 | ₹80 | ₹565 (16.49%) | ₹2400 |
| 09-10-2025 | 485.00 | ₹80 | ₹565 (16.49%) | ₹2400 |
| 08-10-2025 | 485.00 | ₹80 | ₹565 (16.49%) | ₹2400 |
| 07-10-2025 | 485.00 | ₹81 | ₹566 (16.70%) | ₹2,430 |
| 06-10-2025 | 485.00 | ₹80 | ₹565 (16.49%) | ₹2400 |
| 05-10-2025 | 485.00 | ₹68 | ₹553 (14.02%) | ₹2040 |
| 04-10-2025 | 485.00 | ₹60 | ₹545 (12.37%) | ₹1800 |
Rubicon Research IPO Details
| Open Date | Oct 09, 2025 |
|---|---|
| Close Date | Oct 13, 2025 |
| Price Band | ₹461 to ₹485 per share |
| Face Value | ₹1 per equity share |
| Lot Size | 30 Share |
| Type of Issue | Fresh issue & OFS |
| Total Issue Size | 2,84,02,040 shares (aggregating up to ₹1,377.50 Cr) |
| Fresh Issue | 1,03,09,278 shares (aggregating up to ₹500.00 Cr) |
| Offer for Sale | 1,80,92,762 shares of ₹1 (aggregating up to ₹877.50 Cr) |
| Employee Discount | ₹48 per Equity Share |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | BSE & NSE |
| Retail Investor Quota | 35.00% |
| QIB Quota | 50.00% |
| NII (HNI) Quota | 15.00% |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Rubicon Research India Limited
Our Company was originally incorporated on May 6, 1999 as “Rubicon Research Limited” We are a pharmaceutical formulations company, driven by innovation through focused research and development Company.
As on 31, March 2024, we had a Portfolio of 69 active ANDA & New Drug Application Products approved by the US FDA including 55 Commercialized products.
our Company’s portfolio includes 66 Commercialized Products as of March 31, 2025.
we have 17 new products awaiting US FDA ANDA approval and 63 product candidates in various stages of development.
one major chronic disease, such as heart disease, cancer, diabetes, obesity, and hypertension.
We believe our multi-disciplinary, data-driven, and return on investment (“ROI”) centric product selection framework is geared towards identifying sustainable opportunities for new product development. We identify and pursue such opportunities in a manner that provides us a competitive advantage by leveraging our development, manufacturing, and commercialization capabilities to create and grow our share of the market.
Also Read: Rubicon Research IPO Date, Price, GMP, Review, Details
Also Read: LG Electronics IPO Date, Price, GMP, Review, Details
Also Read: Canara HSBC Life IPO GMP Price Today
Also Read: Canara Robeco IPO GMP Price Today
FAQs ON Rubicon Research IPO GMP Today
Q1: What is Rubicon Research IPO GMP today?
Rubicon Research IPO GMP Price is ₹128 Per Share
Q2: What is the Kostak Rate today?
Rubicon Research IPO Kostak Rate is ₹- as of today Not available.
Q3: Rubicon Research ipo gmp investorgain?
Rubicon Research ipo gmp Price investorgain is ₹127 rupay Righ Now
Q4: Rubicon Research ipo gmp ipowatch?
Rubicon Research ipo gmp ipowatch Price is ₹118 rupay Righ Now
Q5: What is the Subject to Sauda rate?
Rubicon Research IPO Subject to Sauda is ₹ 3,200 as of today.
Q6: What are the expected listing gains?
Rubicon Research IPO Estimated 26.39% returns based on current GMP
Disclaimer:
IPO GMP (Grey Market Premium), Kostak and Subject to Sauda Rates are Unofficial and Can Change Quickly.
We do Not BUY or SELL IPO Forms.
Do Not apply For IPOs Based only on GMP Price.
Always Review the company’s fundamentals before investing.
